GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkermes PLC (FRA:8AK) » Definitions » E10

Alkermes (FRA:8AK) E10 : €-0.51 (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Alkermes E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Alkermes's adjusted earnings per share data for the three months ended in Sep. 2024 was €0.496. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.51 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was 0.90% per year. During the past 5 years, the average E10 Growth Rate was -3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Alkermes was 60.70% per year. The lowest was -225.50% per year. And the median was -0.65% per year.

As of today (2024-12-12), Alkermes's current stock price is €28.80. Alkermes's E10 for the quarter that ended in Sep. 2024 was €-0.51. Alkermes's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Alkermes was 3677.06. The lowest was 492.18. And the median was 629.81.


Alkermes E10 Historical Data

The historical data trend for Alkermes's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alkermes E10 Chart

Alkermes Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.71 -0.74 -0.72 -0.86 -0.69

Alkermes Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.77 -0.69 -0.67 -0.64 -0.51

Competitive Comparison of Alkermes's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Alkermes's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkermes's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkermes's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Alkermes's Shiller PE Ratio falls into.



Alkermes E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alkermes's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.496/121.5939*121.5939
=0.496

Current CPI (Sep. 2024) = 121.5939.

Alkermes Quarterly Data

per share eps CPI Adj_EPS
201412 0.162 99.576 0.198
201503 -0.194 99.975 -0.236
201506 -0.276 100.573 -0.334
201509 -0.481 100.274 -0.583
201512 -0.422 99.676 -0.515
201603 -0.458 99.676 -0.559
201606 -0.276 101.072 -0.332
201609 -0.365 100.274 -0.443
201612 -0.133 99.676 -0.162
201703 -0.421 100.374 -0.510
201706 -0.249 100.673 -0.301
201709 -0.201 100.474 -0.243
201712 -0.051 100.075 -0.062
201803 -0.324 100.573 -0.392
201806 -0.180 101.072 -0.217
201809 -0.189 101.371 -0.227
201812 -0.053 100.773 -0.064
201903 -0.549 101.670 -0.657
201906 -0.239 102.168 -0.284
201909 -0.309 102.268 -0.367
201912 -0.027 102.068 -0.032
202003 -0.217 102.367 -0.258
202006 -0.169 101.769 -0.202
202009 -0.001 101.072 -0.001
202012 -0.222 101.072 -0.267
202103 -0.118 102.367 -0.140
202106 0.008 103.364 0.009
202109 -0.153 104.859 -0.177
202112 0.009 106.653 0.010
202203 -0.200 109.245 -0.223
202206 -0.170 112.779 -0.183
202209 -0.394 113.504 -0.422
202212 -0.160 115.436 -0.169
202303 -0.233 117.609 -0.241
202306 1.274 119.662 1.295
202309 0.262 120.749 0.264
202312 0.605 120.749 0.609
202403 0.193 120.990 0.194
202406 0.492 122.318 0.489
202409 0.496 121.594 0.496

Add all the adjusted EPS together and divide 10 will get our e10.


Alkermes  (FRA:8AK) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Alkermes was 3677.06. The lowest was 492.18. And the median was 629.81.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Alkermes E10 Related Terms

Thank you for viewing the detailed overview of Alkermes's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkermes Business Description

Traded in Other Exchanges
Address
1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Alkermes Headlines

No Headlines